Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen

Raziskovalci (1)

št.	Evidenčna št.	Ime in priimek	Razisk. področje	Vloga	Obdobje	Štev. publikacijŠtev. publikacij
1.	11711	dr. Vita Dolžan	Biokemija in molekularna biologija	Vodja	2016 - 2020	765

Organizacije (1)

št.	Evidenčna št.	Razisk. organizacija	Kraj	Matična številka	Štev. publikacijŠtev. publikacij
1.	0381	Univerza v Ljubljani, Medicinska fakulteta	Ljubljana	1627066	48.265

Povzetek

Pharmacogenomics is the study of genetic variability affecting an individual’s response to a drug. Its use allows personalized medicine and reduction in ‘trial and error’ prescribing leading to more efficacious, safer and cost-effective drug therapy. The U-PGx consortium will investigate a pre-emptive genotyping approach (that is: multiple pharmacogenomic variants are collected prospectively and embedded into the patients’ electronic record) of a panel of important pharmacogenomic variants as a new model of personalised medicine. To meet this goal we combine existing pharmacogenomics guidelines and novel health IT solutions. Implementation will be conducted at a large scale in seven existing European health care environments and accounts for the diversity in health system organisations and settings. Feasibility, health outcome and cost-effectiveness will be investigated. We will formulate European strategies for improving clinical implementation of pharmacogenomics based on the findings of this project.

Filtri

Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen

Zgodovina ogledov

Priljubljeno

Filtri

Ubiquitous Pharmacogenomics (U-PGx): Making actionable pharmacogenomic data and effective treatment optimization accessible to every European citizen

Zahtevana je potrditev

Zgodovina ogledov

Priljubljeno